# Tenet Healthcare Corp: Form 10-Q for the period ended Jun 30, 2020

- Company: [Tenet Healthcare Corp](/companies/thc.md) (CIK 70318)
- Form: 10-Q
- Filed: 2020-08-03
- Accepted by EDGAR: Aug 3, 2020, 16:19 ET
- Period: 2020-06-30
- Accession: 0000070318-20-000036
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/70318/000007031820000036/thc-20200630.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/70318/000007031820000036/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2020-04-01 to 2020-06-30 | $3.65bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months, 2020-01-01 to 2020-06-30 | $8.17bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Operating income | 3 months, 2020-04-01 to 2020-06-30 | $471.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2020-01-01 to 2020-06-30 | $798.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2020-04-01 to 2020-06-30 | $255.0m | us-gaap:InterestExpense |
| Interest expense | 6 months, 2020-01-01 to 2020-06-30 | $498.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2020-04-01 to 2020-06-30 | $45.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2020-01-01 to 2020-06-30 | −$30.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2020-04-01 to 2020-06-30 | $169.0m | us-gaap:ProfitLoss |
| Net income | 6 months, 2020-01-01 to 2020-06-30 | $328.0m | us-gaap:ProfitLoss |
| Diluted EPS | 3 months, 2020-04-01 to 2020-06-30 | $0.83 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2020-01-01 to 2020-06-30 | $1.71 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2020-04-01 to 2020-06-30 | $0.84 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2020-01-01 to 2020-06-30 | $1.73 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2020-04-01 to 2020-06-30 | 105,578,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2020-01-01 to 2020-06-30 | 105,656,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2020-01-01 to 2020-06-30 | $2.37bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2020-04-01 to 2020-06-30 | $106.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Capital expenditure | 6 months, 2020-01-01 to 2020-06-30 | $288.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2020-06-30 | $3.51bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2020-06-30 | $7.95bn | us-gaap:AssetsCurrent |
| Total assets | at 2020-06-30 | $26.25bn | us-gaap:Assets |
| Current liabilities | at 2020-06-30 | $5.58bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2020-06-30 | $24.06bn | us-gaap:Liabilities |
| Shareholders' equity | at 2020-06-30 | −$257.0m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/70318/000007031820000036/thc-20200630.htm

Filed Aug 3, 2020.
Source: SEC EDGAR, the filing index for accession 0000070318-20-000036. Last ingested by Listed: Nov 15, 2026, 02:42 ET. No prices; not investment advice.
